Get notified when SYK files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsRisk Profile Improvements
- Material Cybersecurity Incident With Ongoing Investigation (new) — March 11, 2026 breach disrupted operations and impacted Q1 financials; investigation continues with potential for further adverse impacts.
- Legacy It Systems With Ineffective Security (new) — Company disclosed legacy third-party software components protected by layered security that may not be effective against exploitation.
Stryker Q1 sales +2.6%, adj. EPS -8.5% as March cybersecurity breach disrupts operations
Filed May 11, 2026 · Period ending March 31, 2026 · Compared to 10-Q May 2, 2025 · ~2 min read
Key Changes
-
high
March 11, 2026 cybersecurity incident disrupted corporate network and manufacturing, causing material impact to Q1 results. Investigation ongoing; company warns of potential further financial and reputational impacts despite restored operations.
Risk Factors: Cybersecurity Incident verify on EDGAR → -
high
Gross margin compressed 50 basis points to 63.3% as idle production time from the cyber incident drove 200bps manufacturing cost headwind. MedSurg segment margin fell 300bps to 21.8%, Orthopaedics margin down 30bps to 30.1%.
MD&A: Gross Margin & Segment Results verify on EDGAR → -
high
Organic constant-currency sales growth decelerated to 1.0% (reported 2.6%) from 10.1% prior year. Orthopaedics organic growth slowed to 4.1% from 9.3% as operational disruptions impacted order fulfillment.
MD&A: Sales Growth verify on EDGAR →
2 more material changes behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.
Want to see a complete report first? Today's free report (LZB 10-K) is open in full — no account needed.
Partner
Trade SYK commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Generated by AI · Jul 1, 2026 12:47 AM